1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Europe Lung Cancer Therapy Market, by Country

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Lung Cancer Therapy Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Increase in Cases of Lung Cancer

4.1.2 Government Initiatives for Screening and Treatment of Lung Cancer

4.2 Market Restraints

4.2.1 High Cost of Lung Cancer Therapy

4.3 Market Opportunities

4.3.1 Rising Number of Lung Cancer Therapy in Clinical Trials

4.4 Future Trends

4.4.1 Growing Demand for Targeted Therapy

4.5 Impact Analysis:

5. Lung Cancer Therapy Market - Europe Market Analysis

5.1 Europe Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

6. Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Therapy Type

6.1 Overview

6.2 Europe Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

6.3 Non-Invasive Therapy

6.3.1 Overview

6.3.2 Non-Invasive Therapy: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Minimally Invasive

6.4.1 Overview

6.4.2 Minimally Invasive: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4.3 Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

7. Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Indication

7.1 Overview

7.2 Europe Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

7.3 Non-Small Cell Lung Cancer

7.3.1 Overview

7.3.2 Non-Small Cell Lung Cancer: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Small Cell Lung Cancer

7.4.1 Overview

7.4.2 Small Cell Lung Cancer: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Europe Lung Cancer Therapy Market Revenue Share, by End User, 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Oncology Clinics

8.4.1 Overview

8.4.2 Oncology Clinics: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Research Centers

8.5.1 Overview

8.5.2 Research Centers: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Lung Cancer Therapy Market - Country Analysis

9.1.1 Europe Lung Cancer Therapy Market, by Country

9.1.1.1 UK

9.1.1.1.1 Overview

9.1.1.1.2 UK: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.1.3 UK: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.1.3.1 UK: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.1.4 UK: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.1.5 UK: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.2 Germany

9.1.1.2.1 Overview

9.1.1.2.2 Germany: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.2.3 Germany: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.2.3.1 Germany: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.2.4 Germany: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.2.5 Germany: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.3 France

9.1.1.3.1 Overview

9.1.1.3.2 France: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.3.3 France: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.3.3.1 France: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.3.4 France: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.3.5 France: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.4 Italy

9.1.1.4.1 Overview

9.1.1.4.2 Italy: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.4.3 Italy: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.4.3.1 Italy: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.4.4 Italy: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.4.5 Italy: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.5 Spain

9.1.1.5.1 Overview

9.1.1.5.2 Spain: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.5.3 Spain: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.5.3.1 Spain: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.5.4 Spain: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.5.5 Spain: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.6 Russia

9.1.1.6.1 Overview

9.1.1.6.2 Russia: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.6.3 Russia: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.6.3.1 Russia: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.6.4 Russia: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.6.5 Russia: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.7 Rest of Europe

9.1.1.7.1 Overview

9.1.1.7.2 Rest of Europe: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.7.3 Rest of Europe: Europe Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.7.3.1 Rest of Europe: Europe Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.7.4 Rest of Europe: Europe Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.7.5 Rest of Europe: Europe Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

10. Lung Cancer Therapy Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in Europe Lung Cancer Therapy Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 RF Medical Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Johnson & Johnson

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck KGaA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sun Pharmaceutical Industries Ltd

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Bioventus Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Olympus Corp

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Meiji Seika Pharma Co Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Advanz Pharma Corp

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Europe Lung Cancer Therapy Market Segmentation

Table 2. Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 3. UK: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 4. UK: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 5. UK: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 6. UK: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 7. Germany: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. Germany: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 10. Germany: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 11. France: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. France: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 13. France: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 14. France Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 15. Italy Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 16. Italy: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 17. Italy: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 18. Italy: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 19. Spain: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 20. Spain: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 21. Spain: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 22. Spain: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 23. Russia: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 24. Russia: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 25. Russia: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 26. Russia: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 27. Rest of Europe: Europe Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 28. Rest of Europe: Europe Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 29. Rest of Europe: Europe Lung Cancer Therapy Market, by Indication- Revenue and Forecast to 2030 (US$ Million)

Table 30. Rest of Europe: Europe Lung Cancer Therapy Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 31. Recent Inorganic Growth Strategies in the Europe Lung Cancer Therapy Market

Table 32. Recent Organic Growth Strategies in Europe Lung Cancer Therapy Market

Table 33. Glossary of Terms, Europe Lung Cancer Therapy Market

List of Figures

Figure 1. Europe Lung Cancer Therapy Market Segmentation, By Country

Figure 2. Europe Lung Cancer Therapy Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Europe Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

Figure 6. Non-Invasive Therapy: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Minimally Invasive: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Europe Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

Figure 9. Non-Small Cell Lung Cancer: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Small Cell Lung Cancer: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Europe Lung Cancer Therapy Market Revenue Share, End User, 2022 & 2030 (%)

Figure 12. Hospitals: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Oncology Clinics: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Research Centers: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: Europe Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Europe Lung Cancer Therapy Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 17. Europe Lung Cancer Therapy Market, By Key Countries, 2022 and 2030 (%)

Figure 18. UK: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 19. Germany: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 20. France: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Italy: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. Spain: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Russia: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Rest of Europe: Europe Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Growth Strategies in Europe Lung Cancer Therapy Market